Foresite Capital Management Iv, LLC Replimune Group, Inc. Transaction History

Foresite Capital Management Iv, LLC

  • $149 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$10.01 - $16.87 $12.3 Million - $20.7 Million
-1,228,656 Closed
0 $0
Q2 2019

Aug 13, 2019
SELL
$12.51 - $17.28 $12,510 - $17,280
-1,000 Reduced 0.08%
1,228,656 $18 Million
Q3 2018

Nov 13, 2018
BUY
$14.99 - $22.14 $18.4 Million - $27.2 Million
1,229,656 New
1,229,656 $19.8 Million

Others Institutions Holding REPL

# of Institutions
155
Shares Held
70M
Call Options Held
26.7K
Put Options Held
28.6K
View Full List

About Replimune Group, Inc.

REPL Quotes by TradingView
  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $597M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Foresite Capital Management Iv, LLC Portfolio

Follow Foresite Capital Management Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email